vs
NeuroPace Inc（NPCE）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
NeuroPace Inc的季度营收约是RIVERVIEW BANCORP INC的1.9倍（$26.6M vs $14.0M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -10.3%，领先20.1%），NeuroPace Inc同比增速更快（23.9% vs 10.4%），NeuroPace Inc自由现金流更多（$409.0K vs $-736.0K），过去两年RIVERVIEW BANCORP INC的营收复合增速更高（24.6% vs 21.1%）
NeuroPace Inc是一家专注于神经调控技术的医疗科技企业，核心产品为可植入式响应神经刺激系统，主要用于治疗药物难治性癫痫，通过与医疗机构合作，为北美及部分全球市场的患者提供个性化治疗方案，降低癫痫发作频率。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
NPCE vs RVSB — 直观对比
营收规模更大
NPCE
是对方的1.9倍
$14.0M
营收增速更快
NPCE
高出13.5%
10.4%
净利率更高
RVSB
高出20.1%
-10.3%
自由现金流更多
NPCE
多$1.1M
$-736.0K
两年增速更快
RVSB
近两年复合增速
21.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $26.6M | $14.0M |
| 净利润 | $-2.7M | $1.4M |
| 毛利率 | 77.4% | — |
| 营业利润率 | -6.6% | 12.4% |
| 净利率 | -10.3% | 9.8% |
| 营收同比 | 23.9% | 10.4% |
| 净利润同比 | 48.0% | 11.8% |
| 每股收益（稀释后） | $-0.08 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NPCERVSB
| Q4 25 | $26.6M | $14.0M | ||
| Q3 25 | $27.4M | $13.6M | ||
| Q2 25 | $23.5M | $13.3M | ||
| Q1 25 | $22.5M | $12.9M | ||
| Q4 24 | $21.5M | $12.7M | ||
| Q3 24 | $21.1M | $12.8M | ||
| Q2 24 | $19.3M | $12.2M | ||
| Q1 24 | $18.1M | $9.0M |
净利润NPCERVSB
| Q4 25 | $-2.7M | $1.4M | ||
| Q3 25 | $-3.5M | $1.1M | ||
| Q2 25 | $-8.7M | $1.2M | ||
| Q1 25 | $-6.6M | $1.1M | ||
| Q4 24 | $-5.3M | $1.2M | ||
| Q3 24 | $-5.5M | $1.6M | ||
| Q2 24 | $-7.5M | $966.0K | ||
| Q1 24 | $-8.9M | $-3.0M |
毛利率NPCERVSB
| Q4 25 | 77.4% | — | ||
| Q3 25 | 77.4% | — | ||
| Q2 25 | 77.1% | — | ||
| Q1 25 | 77.0% | — | ||
| Q4 24 | 75.4% | — | ||
| Q3 24 | 73.2% | — | ||
| Q2 24 | 73.4% | — | ||
| Q1 24 | 73.6% | — |
营业利润率NPCERVSB
| Q4 25 | -6.6% | 12.4% | ||
| Q3 25 | -9.5% | 10.2% | ||
| Q2 25 | -29.0% | 11.7% | ||
| Q1 25 | -22.9% | 11.3% | ||
| Q4 24 | -17.0% | 12.4% | ||
| Q3 24 | -20.1% | 15.5% | ||
| Q2 24 | -32.4% | 10.0% | ||
| Q1 24 | -41.6% | -47.5% |
净利率NPCERVSB
| Q4 25 | -10.3% | 9.8% | ||
| Q3 25 | -12.8% | 8.1% | ||
| Q2 25 | -36.8% | 9.2% | ||
| Q1 25 | -29.3% | 8.9% | ||
| Q4 24 | -24.5% | 9.7% | ||
| Q3 24 | -25.9% | 12.2% | ||
| Q2 24 | -39.0% | 7.9% | ||
| Q1 24 | -49.2% | -34.7% |
每股收益（稀释后）NPCERVSB
| Q4 25 | $-0.08 | $0.07 | ||
| Q3 25 | $-0.11 | $0.05 | ||
| Q2 25 | $-0.26 | $0.06 | ||
| Q1 25 | $-0.21 | $0.05 | ||
| Q4 24 | $-0.16 | $0.06 | ||
| Q3 24 | $-0.19 | $0.07 | ||
| Q2 24 | $-0.26 | $0.05 | ||
| Q1 24 | $-0.32 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $61.1M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $19.0M | $164.2M |
| 总资产 | $105.6M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NPCERVSB
| Q4 25 | $61.1M | $28.6M | ||
| Q3 25 | $60.0M | $32.8M | ||
| Q2 25 | $62.1M | $34.2M | ||
| Q1 25 | $66.3M | $29.4M | ||
| Q4 24 | $52.8M | $25.3M | ||
| Q3 24 | $56.8M | $31.0M | ||
| Q2 24 | $55.5M | $27.8M | ||
| Q1 24 | $58.9M | $23.6M |
股东权益NPCERVSB
| Q4 25 | $19.0M | $164.2M | ||
| Q3 25 | $18.5M | $163.5M | ||
| Q2 25 | $19.4M | $162.0M | ||
| Q1 25 | $24.3M | $160.0M | ||
| Q4 24 | $8.0M | $158.3M | ||
| Q3 24 | $9.8M | $160.8M | ||
| Q2 24 | $9.9M | $155.9M | ||
| Q1 24 | $14.3M | $155.6M |
总资产NPCERVSB
| Q4 25 | $105.6M | $1.5B | ||
| Q3 25 | $107.3M | $1.5B | ||
| Q2 25 | $106.1M | $1.5B | ||
| Q1 25 | $110.2M | $1.5B | ||
| Q4 24 | $94.6M | $1.5B | ||
| Q3 24 | $96.3M | $1.5B | ||
| Q2 24 | $94.4M | $1.5B | ||
| Q1 24 | $98.9M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $506.0K | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $409.0K | $-736.0K |
| 自由现金流率自由现金流/营收 | 1.5% | -5.2% |
| 资本支出强度资本支出/营收 | 0.4% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | $-11.3M | $20.4M |
8季度趋势，按日历期对齐
经营现金流NPCERVSB
| Q4 25 | $506.0K | $-506.0K | ||
| Q3 25 | $-1.9M | $16.8M | ||
| Q2 25 | $-2.1M | $-697.0K | ||
| Q1 25 | $-7.5M | $8.3M | ||
| Q4 24 | $-4.8M | $2.2M | ||
| Q3 24 | $-1.7M | $764.0K | ||
| Q2 24 | $-3.9M | $5.4M | ||
| Q1 24 | $-7.5M | $12.8M |
自由现金流NPCERVSB
| Q4 25 | $409.0K | $-736.0K | ||
| Q3 25 | $-2.0M | $16.4M | ||
| Q2 25 | $-2.3M | $-773.0K | ||
| Q1 25 | $-7.5M | $5.6M | ||
| Q4 24 | $-4.8M | $1.9M | ||
| Q3 24 | $-1.8M | $-1.4M | ||
| Q2 24 | $-4.0M | $5.3M | ||
| Q1 24 | $-7.6M | $7.1M |
自由现金流率NPCERVSB
| Q4 25 | 1.5% | -5.2% | ||
| Q3 25 | -7.2% | 120.1% | ||
| Q2 25 | -9.6% | -5.8% | ||
| Q1 25 | -33.4% | 43.1% | ||
| Q4 24 | -22.5% | 15.0% | ||
| Q3 24 | -8.7% | -11.3% | ||
| Q2 24 | -20.6% | 43.7% | ||
| Q1 24 | -42.1% | 79.0% |
资本支出强度NPCERVSB
| Q4 25 | 0.4% | 1.6% | ||
| Q3 25 | 0.1% | 2.9% | ||
| Q2 25 | 0.7% | 0.6% | ||
| Q1 25 | 0.2% | 21.0% | ||
| Q4 24 | 0.2% | 2.4% | ||
| Q3 24 | 0.5% | 17.3% | ||
| Q2 24 | 0.3% | 0.9% | ||
| Q1 24 | 0.6% | 62.0% |
现金转化率NPCERVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
